Positron Emission Tomography Applications in Alzheimer's Disease Diagnosis and Management
Summary
Positron emission tomography (PET) has emerged as a cornerstone in the clinical and research landscape of Alzheimer’s disease (AD), offering critical insights into cerebral metabolism and proteinopathy. 18F-fluorodeoxyglucose (FDG) PET reveals regional hypometabolism that correlates with synaptic dysfunction, while PET ligands targeting amyloid-β and tau aggregates enable in vivo visualisation of core AD pathologies. Combined with anatomical imaging or deployed in hybrid PET/MR systems, these modalities facilitate early and differential diagnosis, patient stratification and therapeutic monitoring. Quantitative approaches, including voxel-based and region-of-interest analyses, enhance sensitivity and reproducibility, supporting prognostic assessments and guiding inclusion in clinical trials. Emerging tracers for synaptic density and novel machine-learning pipelines promise to refine the detection of prodromal stages and to monitor treatment response. Globally, PET protocols are being standardised to ensure harmonised data acquisition and interpretation, thereby extending the utility of PET in personalised management and in the development of disease-modifying strategies.
Research from Nature Portfolio
Recent work employing dual-tracer PET has demonstrated that amyloid-β aggregation within the brain’s default mode network induces hypometabolism in functionally connected but spatially distant regions. An interaction between local amyloid burden and remote metabolic vulnerability was found to predict subsequent cognitive decline. Translational studies in transgenic models corroborate this mechanism independently of tau pathology, supporting a novel framework in which distant amyloid accumulation drives regional metabolic deficits that underlie clinical progression.
Positron Emission Tomography Applications in Alzheimer's Disease Diagnosis and Management publication trend
The graph below shows the total number of articles in positron emission tomography applications in alzheimer's disease diagnosis and management across all publications each year (not limited to Nature Index journals).
Technical terms
Positron emission tomography (PET): Functional imaging technique that maps the distribution of radiotracers by detecting gamma rays from positron–electron annihilation.
18F-fluorodeoxyglucose (FDG): Radiolabelled glucose analogue used in PET to measure regional cerebral glucose metabolism as a proxy for synaptic activity.
Amyloid PET tracer: Radioligand designed to bind selectively to amyloid-β plaques, enabling in vivo visualisation of extracellular protein deposits.
Hypometabolism: Reduced metabolic activity in a brain region, often indicative of neuronal or synaptic dysfunction associated with neurodegeneration.
Standardised uptake value ratio (SUVR): Quantitative index of radiotracer uptake normalised to a reference region, allowing comparison across subjects and timepoints.
References
- EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3. European Journal of Nuclear Medicine and Molecular Imaging (2021).
- Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases. NeuroImage Clinical (2016).
- Imaging Techniques in Alzheimer’s Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring. International Journal of Molecular Sciences (2021).
- Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. NeuroImage Clinical (2014).
- FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study. Alzheimer's Research & Therapy (2019).
- VoxelStats: A MATLAB Package for Multi-Modal Voxel-Wise Brain Image Analysis. Frontiers in Neuroinformatics (2016).
- Aβ-induced vulnerability propagates via the brain’s default mode network. Nature Communications (2019).
- PET Approaches for Diagnosis of Dementia. American Journal of Neuroradiology (2013).
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.